Capita3
VC Fund
Minneapolis, United States
Capita3 is a VC fund in Minneapolis focused on Health Care and Health Diagnostics. Capita3 is building a global financing institution for investing in exceptional women leading game-changing companies. In addition to financial investment. They focus on developing startup CEOs to maximize their growth and the company's exit potential.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
- Fund size:
- $1.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Capita3 invests in
Stages Capita3 invests in
Countries Capita3 invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Barb Birr
|
|||
Pamela York
|
|||
Sara Russick
|
|||
Investment Focus
Industry
- Health Care 3 (50%)
- Health Diagnostics 2 (33%)
- EdTech 1 (17%)
- Medical 1 (17%)
- Analytics 1 (17%)
Stage
- Seed 3 (50%)
- Series A 1 (17%)
- Series B 1 (17%)
- Convertible Note 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Barb Birr
Chief Operations Officer
|
Chief Operations Officer | Total investments: 0 | Find email | |
|
Pamela York
Co-Founding General Managing Partner & Managing Director
|
Co-Founding General Managing Partner & Managing Director | Total investments: 0 | Find email | |
|
Sara Russick
Co-Founder & General Managing Partner
|
Co-Founder & General Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Claros Technologies
|
Claros Technologies is an environmental technology company that develops solutions for the detection, analysis, and destruction of per- and polyfluoroalkyl substances (PFAS). The company provides PFAS testing and analytical laboratory services, proprietary PFAS destruction technology, and regulatory compliance solutions for industrial, municipal,and government organizations. Its technologies are designed to help identify, manage, and permanently eliminate PFAS contamination from water, wastewater, and other materials through science-based environmental remediation solutions. | $10M / Convertible Note / Aug 12, 2025 | |
|
Claros Technologies
|
Claros Technologies is an environmental technology company that develops solutions for the detection, analysis, and destruction of per- and polyfluoroalkyl substances (PFAS). The company provides PFAS testing and analytical laboratory services, proprietary PFAS destruction technology, and regulatory compliance solutions for industrial, municipal,and government organizations. Its technologies are designed to help identify, manage, and permanently eliminate PFAS contamination from water, wastewater, and other materials through science-based environmental remediation solutions. | $22M / Series B / May 28, 2024 | |
MDisrupt
|
MDisrupt is health industry expert platform for the digital health industry. We believe the most impactful health products should make it to market faster. | $3M / Seed / May 20, 2023 | |
Astarte Medical
|
Astarte Medical is a clinical intelligence company using software and predictive analytics to improve outcomes for children with medical complexity. Astarte Medical supports standardized care protocols, care planning and decision-making in acute, complex care settings with a suite of digital tools and diagnostics designed to optimize care andoutcomes for vulnerable patient populations when there is great opportunity to impact long-term health. | $7.6M / Series A / Sep 22, 2021 | |
EmpowerU
|
EmpowerU’s highly personalized, online social-emotional learning program helps young people replace anxiety and depression with resilience and confidence, fueling student transformation at a fraction of the cost of therapy. | $1M / Seed / Jan 05, 2021 | |
Marani
|
Marani Health is a leading maternal healthcare technology company dedicated to transforming prenatal and postpartum care through AI-powered remote monitoring solutions. Our flagship platform, M•care System, connects expectant mothers with qualified healthcare professionals through advanced digital health technology, ensuring comprehensive carethroughout pregnancy. Serving health plans, maternity providers, employers, and patients, Marani's solutions enhance clinical workflows, reduce unnecessary interventions, and improve maternal and fetal outcomes. Marani Health is committed to improving maternal and fetal health outcomes while addressing healthcare access disparities in all communities.At Marani Health, we envision a world where every pregnancy is supported by personalized, proactive, and equitable care—empowering mothers and care teams with the tools and insights needed to ensure healthier beginnings for all. | $1.5M / Seed / Aug 12, 2019 |
Co-Investors
American Century Investments
2 deals together
F.R. Bigelow Foundation
2 deals together
University of Minnesota
2 deals together
37 Angels
1 deal together
Ben Franklin Technology Partners of Southeastern Pennsylvania
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Capita3 invest in?
Capita3 invests primarily in Health Care, Health Diagnostics and EdTech startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Capita3?
Public channels for Capita3 include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Capita3?
The team at Capita3 includes Barb Birr (Chief Operations Officer), Pamela York (Co-Founding General Managing Partner & Managing Director) and Sara Russick (Co-Founder & General Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
